The estimated lifetime risk of being diagnosed with myeloma is 1 in 83 (1%) for males, and 1 in 116 (less than 1%) for females born after 1960 in the UK.[1]
These figures have been calculated on the assumption that the possibility of having more than one diagnosis of myeloma over the course of a lifetime is very low (‘Current Probability’ method).[2]

See also
Lifetime risk for all cancers combined and cancers compared
Want to generate bespoke preventable cancers stats statements? Download our interactive statement generator.
References
-
Lifetime risk estimates calculated by the Statistical Information Team at Cancer Research UK. Based on Office for National Statistics (ONS) 2016-based Life expectancies and population projections. Accessed December 2017, and Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.
-
Esteve J, Benhamou E and Raymond L. Descriptive epidemiology. IARC Scientific Publications No.128, Lyon, International Agency for Research on Cancer, pp 67-68 1994.
About this data
Data is for UK, past and projected cancer incidence and mortality and all-cause mortality rates for those born in 1961, ICD-10 C90.
The calculations used past and projected cancer incidence and mortality and all-cause mortality rates for those born in 1961 to project risk over the lifetime of those born in 1961 (cohort method).[1] Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment.